Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Set Alert for Commercial

Earnings Winners & Losers: MMSI, STMN, WMGI, RWLK, EXAS

As the earnings season continues, Medtech Insight takes a look at dental firm Straumann’s performance, as well as that of some mid- to small-cap companies – including extremities implant specialist Wright Medical – highlighting which we believe to be the season’s winners and losers.

Sales & Earnings Companies Commercial


Set Alert for Companies

Latest From Companies

New Products Drive Medtronic’s Revenue, Profit Growth In Q3

The medtech giant announced 6% revenue growth, led by the cardiac and vascular and diabetes groups, both of which are enjoying strong market demand for new products. Medtronic expects to continue growing revenues by about five percent annually to maintain double-digit earnings growth.

Cardiology Diabetic Care

Siemens Healthineers To Launch Digital 'One-Stop-Shop'

Siemens Healthineers is set to launch a new digital platform for healthcare providers and technology companies to share data, applications and services. The company presented a prototype of the new digital platform at the Healthcare Information and Management Systems Society (HIMSS) healthcare IT conference in Orlando, Florida.

Digital Health Innovation

Efferent Labs' Living Biosensor Could Save Pharma, Device Firms Money

A new implantable cell-based monitoring device that measure cellular interactions in vivo could soon reach the research market to help medical device and pharma companies in their preclinical, and later this year clinical, research. After that, the technology's developer, Efferent Labs, will be setting its sights on clinical applications like chemotherapy monitoring in cancer patients.

Diagnostics Companies
See All

Deals and Financings

Set Alert for Deals

Latest From Deals

Device Week – Feb. 17, 2017

On this week's Medtech Insight podcast: US House Ways and Means Committee sets out plans for the next two years, including a review of all taxes and fees connected to the Affordable Care Act; Allergan and Hologic enter into separate big-money acquisitions in the aesthetics devices arena; a deep-dive look at the osteoporosis diagnostics market.

Regulation Policy

Integra Aims To Bolster Neurology Portfolio With J&J Codman Buy

Only a month after buying the tissue regeneration company Derma Sciences, Integra has announced a much larger acquisition for Codman Neurosurgery. The company says the buy would complement its current neurosurgery portfolio and boost its global reach.

Neurology Deals

'Selective' JDRF Backs Israeli Injectable Blood Glucose Monitor

An Israeli start-up developing an injectable, miniature continuous blood glucose monitoring implant has secured funding from the Juvenile Diabetes Research Foundation (JDRF) to speed up product development. The investment will be used to bring GluSense closer to its first in-human clinical trial.

Diabetic Care Innovation
See All

Market Access

Set Alert for Market Access

Latest From Market Access

Russia's Medtech Looks For Chain Reaction After Philips Partnership Deal

Russia's health care sector has been under strain, suffering budgets cuts and repercussions from the ongoing sanctions. In the midst of this, plans to reinforce the local medtech industry received a boost recently when global top 10 manufacturer Philips Healthcare committed funds to embarking on new R&D locally and to further partnerships in Russia.

Russian Federation Market Access

Australia To Make Access To Unauthorized Products Faster And Less Bothersome

New proposals by Australia’s Therapeutic Goods Administration include developing a list of unauthorized medical devices that could be made available to patients faster and more easily. A decision to include a product on the list would not be appealable, the TGA says.

Market Access Regulation

£9m NHS Savings With HeartFlow 'Virtual FFR' Gets NICE Nod

UK's National Institute for Health and Care Excellence has recommended the HeartFlow FFRct Analysis for stable patients with a suspected myocardial infarction. NICE was won over by the potential £9m savings that the technology can bring to the National Health Services in the next five years.

Cardiology Diagnostic Imaging
See All

Market Intelligence

Set Alert for Market Intelligence

Latest From Market Intelligence

Infusion Pump-Makers Look to Improve Safety Through Interoperability

While infusion pumps are vital to patient care and used in abundance in hospitals, they are also associated with numerous errors. One of the keys to addressing this problem lies in improving the devices’ interoperability with hospital IT systems, and as those changes are starting to materialize, so are opportunities for new players in this space.

Safety Market Intelligence

Expanding Elderly Population Gives Leg Up To Osteoporosis Dx Growth

The global market for osteoporosis diagnostic products is expected to expand from $253m in 2015 to $304m by 2020, fueled by a rising aging population and the need to test for osteoporosis and associated fracture risk. This article offers an in-depth look at the growth markets for both bone densitometer testing and biochemical marker tests, as well as the evolving competitive landscape, and the drivers and barriers to market entry.

Orthopedics Market Intelligence

Emerging Markets Are Fertile Frontier For CRM Device-Makers

The global cardiac rhythm management market is set to grow at a compound annual growth rate of 4.8% to about $13.5bn by 2021. This article, based on findings from a Meddevicetracker report, provides an in-depth look at where the growth markets are, the evolving competitive landscape, and discusses the key players and upcoming technological trends that will bolster this market.

Cardiology Market Intelligence
See All


Set Alert for Appointments

Latest From People

J&J Device Chief Gary Pruden Retiring; Sandra Peterson Will Take On Duties

Sandra Peterson, Johnson & Johnson group worldwide chair, will take on leadership of the company’s hospital medical device business on June 1 when Gary Pruden, worldwide chair of medical devices, retires.

Commercial People

Former Zimmer Biomet Exec To Head Clinical Affairs At MDIC

Jing Xie has moved from Zimmer Biomet to the Medical Device Innovation Consortium to serve as the public-private partnership's first VP of clinical affairs.

People Regulation

AXREM Names Siemens Healthineers MD As Chairman

UK imaging and radiotherapy trade association AXREM has named Peter Harrison, managing director of Siemens Healthcare in the UK, as chairman for 2017-18.

People Medical Device
See All